دورية أكاديمية
أعرض في EDS

Risk Factors Associated with Cystoid Macular Edema among Patients Undergoing Primary Repair of Rhegmatogenous Retinal Detachment.

التفاصيل البيبلوغرافية
العنوان: Risk Factors Associated with Cystoid Macular Edema among Patients Undergoing Primary Repair of Rhegmatogenous Retinal Detachment.
المؤلفون: Shah YS; Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland., Abidi M; Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland., Ahmed I; Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland; Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts., Arsiwala-Scheppach LT; Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland; Wilmer Biostatistics Center, Johns Hopkins School of Medicine, Baltimore, Maryland., Ong SS; Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland; Department of Ophthalmology, Wake Forest School of Medicine, Winston-Salem, North Carolina., Wu D; Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland; Department of Ophthalmology, Massachusetts Eye and Ear, Boston, Massachusetts., Handa JT; Johns Hopkins Wilmer Eye Institute, Baltimore, Maryland. Electronic address: jthanda@jhmi.edu.
المصدر: Ophthalmology. Retina [Ophthalmol Retina] 2024 May; Vol. 8 (5), pp. 456-464. Date of Electronic Publication: 2023 Nov 29.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Published by Elsevier Inc. on behalf of American Academy of Ophthalmology Country of Publication: United States NLM ID: 101695048 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2468-6530 (Electronic) Linking ISSN: 24686530 NLM ISO Abbreviation: Ophthalmol Retina Subsets: MEDLINE
أسماء مطبوعة: Original Publication: New York, NY : Published by Elsevier Inc. on behalf of American Academy of Ophthalmology, [2017]-
مواضيع طبية MeSH: Retinal Detachment*/surgery , Retinal Detachment*/diagnosis , Retinal Detachment*/etiology , Macular Edema*/etiology , Macular Edema*/diagnosis , Visual Acuity* , Tomography, Optical Coherence*/methods , Vitrectomy*/adverse effects , Vitrectomy*/methods, Humans ; Retrospective Studies ; Cross-Sectional Studies ; Male ; Female ; Risk Factors ; Middle Aged ; Postoperative Complications/epidemiology ; Follow-Up Studies ; Aged ; Scleral Buckling/methods ; Scleral Buckling/adverse effects
مستخلص: Purpose: To investigate predictors of the development and resolution of cystoid macular edema (CME) after rhegmatogenous retinal detachment (RRD) repair.
Design: Retrospective cross sectional study.
Subjects: Patients who underwent primary repair of uncomplicated RRD.
Methods: Demographics, ophthalmic history, visual acuity, RRD features, time to development/resolution of CME, OCT characteristics of CME/epiretinal membrane (ERM), type of surgery, and treatments were collected. Logistic regressions were used to identify predictors of CME development and resolution.
Main Outcome Measures: Predictors of CME development and resolution.
Results: A total of 708 eyes were included, of which 55 (7.8%) developed CME. Factors associated with an increased risk of CME development included total number of retinal detachment surgeries (odds ratio [OR] 1.66 [1.24-2.23], P < 0.001), prior intraocular surgery (OR 4.43 [1.19-16.51], P = 0.03), and presence of ERM after surgery (OR 4.49 [2.30-8.74], P < 0.001). Patients undergoing pars plana vitrectomy (PPV) were more likely to develop CME compared with patients undergoing scleral buckling (SB; OR 3.09 [1.18-8.10], P = 0.02). A longer average time to CME detection was associated with lower CME resolution (OR 0.94 [0.89-0.998], P = 0.04). In patients who developed an ERM postsurgically, those who developed CME after ERM had a lower rate of resolution compared with those who developed CME before ERM (P = 0.03).
Conclusions: Cystoid macular edema may be more likely to develop in patients undergoing PPV than SB, those who underwent more surgeries for RRD repair, those who had prior intraocular surgery, or those who developed an ERM after RRD repair. Resolution of CME may be affected by the time to detection of CME and ERM development.
Financial Disclosure(s): Proprietary or commercial disclosure may be found in the Footnotes and Disclosures at the end of this article.
(Copyright © 2023 American Academy of Ophthalmology. Published by Elsevier Inc. All rights reserved.)
References: Pharmacogenomics. 2007 Jan;8(1):49-66. (PMID: 17187509)
Br J Ophthalmol. 2000 May;84(5):506-11. (PMID: 10781515)
Prog Retin Eye Res. 2018 Mar;63:20-68. (PMID: 29126927)
Eur J Ophthalmol. 2015 Nov-Dec;25(6):565-70. (PMID: 25907288)
Am J Ophthalmol. 2019 Jul;203:12-25. (PMID: 30772349)
Proc Natl Acad Sci U S A. 1999 Sep 14;96(19):10836-41. (PMID: 10485912)
Ocul Immunol Inflamm. 2021 Jan 2;29(1):187-192. (PMID: 31577459)
Am J Ophthalmol. 1989 Jul 15;108(1):22-9. (PMID: 2750831)
Graefes Arch Clin Exp Ophthalmol. 1986;224(1):13-7. (PMID: 3943728)
Acta Ophthalmol. 2022 May;100(3):295-301. (PMID: 34137182)
Am J Ophthalmol. 2017 Mar;175:99-113. (PMID: 27993592)
Br J Ophthalmol. 2010 Jun;94(6):678-84. (PMID: 19515646)
J Cataract Refract Surg. 2012 Aug;38(8):1389-97. (PMID: 22814044)
Lab Invest. 2014 May;94(5):569-85. (PMID: 24614198)
Arch Ophthalmol. 1980 Jul;98(7):1230-2. (PMID: 7396774)
Mediators Inflamm. 2013;2013:971758. (PMID: 24288446)
Retina. 2016 Oct;36(10):1823-42. (PMID: 27328171)
Eye (Lond). 2007 Jun;21(6):831-4. (PMID: 16710429)
Retina. 2022 Jul 1;42(7):1268-1276. (PMID: 35316255)
Invest Ophthalmol Vis Sci. 2011 Jan 05;52(1):249-55. (PMID: 20720227)
Br J Ophthalmol. 2014 Jul;98 Suppl 2:ii24-9. (PMID: 24934220)
Arch Ophthalmol. 1981 May;99(5):873-80. (PMID: 7016092)
Curr Mol Med. 2013 Jul;13(6):911-28. (PMID: 23651348)
Semin Immunopathol. 2008 Apr;30(2):165-77. (PMID: 18305941)
Eye (Lond). 2017 Apr;31(4):566-571. (PMID: 27935601)
Clin Exp Ophthalmol. 2016 Mar;44(2):128-34. (PMID: 26317489)
Am J Ophthalmol. 1978 Feb;85(2):181-91. (PMID: 623188)
Eye (Lond). 2023 Mar;37(4):684-691. (PMID: 35338355)
Ophthalmology. 2016 Jan;123(1):P152-81. (PMID: 26578445)
Antioxidants (Basel). 2019 Dec 20;9(1):. (PMID: 31861871)
معلومات مُعتمدة: P30 EY001765 United States EY NEI NIH HHS
فهرسة مساهمة: Keywords: Cystoid macular edema; Epiretinal membrane; Rhegmatogenous retinal detachment; Risk factors
تواريخ الأحداث: Date Created: 20231130 Date Completed: 20240504 Latest Revision: 20240507
رمز التحديث: 20240507
مُعرف محوري في PubMed: PMC11070291
DOI: 10.1016/j.oret.2023.11.013
PMID: 38036083
قاعدة البيانات: MEDLINE
الوصف
تدمد:2468-6530
DOI:10.1016/j.oret.2023.11.013